We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+13.61%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$131B
AUM Growth
+$4.38B
(+3.5%)
Cap. Flow
-$8.55B
Cap. Flow
% of AUM
-6.54%
Top 10 Holdings %
Top 10 Hldgs %
31.78%
Holding
338
New
5
Increased
60
Reduced
234
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$985M |
| 2 |
Amazon
AMZN
|
+$718M |
| 3 |
Fair Isaac
FICO
|
+$244M |
| 4 |
ConocoPhillips
COP
|
+$233M |
| 5 |
IDEX
IEX
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.06B |
| 2 |
Eli Lilly
LLY
|
+$1.01B |
| 3 |
Oracle
ORCL
|
+$929M |
| 4 |
KLA
KLAC
|
+$882M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$494M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.46% |
| 2 | Healthcare | 24.26% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 11.4% |
| 5 | Financials | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
TJX Companies
TJX
$178B
| $1.52B | 1.17% |
10,524,552
-1,012,340
| -9% | -$134M |
|
27
Ross Stores
ROST
$81.9B
| $1.52B | 1.16% |
9,954,910
-313,790
| -3% | -$44.8M |
|
|
28
Alphabet (Google) Class C
GOOG
$4.32T
| $1.49B | 1.14% |
6,126,946
-2,349,411
| -28% | -$494M |
|
29
Visa
V
$677B
| $1.39B | 1.06% |
4,064,781
-182,762
| -4% | -$63.3M |
|
30
Adobe
ADBE
$105B
| $1.36B | 1.04% |
3,857,505
-300,031
| -7% | -$108M |
|
31
Wells Fargo
WFC
$264B
| $1.25B | 0.96% |
14,926,855
-3,251,105
| -18% | -$264M |
|
32
JPMorgan Chase
JPM
$950B
| $1.21B | 0.93% |
3,838,067
-1,207,060
| -24% | -$359M |
|
33
Novartis
NVS
$297B
| $1.2B | 0.92% |
9,341,854
-1,059,580
| -10% | -$129M |
|
34
Aecom
ACM
$9.75B
| $1.16B | 0.89% |
8,878,363
-684,889
| -7% | -$82.7M |
|
35
NetApp
NTAP
$37.2B
| $1.14B | 0.87% |
9,630,055
-1,536,790
| -14% | -$172M |
|
36
Thermo Fisher Scientific
TMO
$220B
| $1.12B | 0.86% |
2,303,322
-102,870
| -4% | -$47.9M |
|
37
GSK
GSK
$106B
| $1.11B | 0.85% |
25,766,950
-1,959,830
| -7% | -$76.6M |
|
38
Delta Air Lines
DAL
$60.1B
| $1.04B | 0.8% |
18,293,987
-1,899,845
| -9% | -$108M |
|
39
Northern Trust
NTRS
$33.9B
| $1.02B | 0.78% |
7,541,367
-252,390
| -3% | -$32.5M |
|
40
Elanco Animal Health
ELAN
$11.1B
| $1.01B | 0.77% |
49,958,156
-1,808,658
| -3% | -$30.3M |
|
41
Bristol-Myers Squibb
BMY
$132B
| $996M | 0.76% |
22,094,320
-850,330
| -4% | -$39.7M |
|
|
42
Chevron
CVX
$366B
| $988M | 0.76% |
+6,362,826
| New | +$985M |
|
|
43
ConocoPhillips
COP
$141B
| $979M | 0.75% |
10,351,010
+2,467,555
| +31% | +$233M |
|
44
Royal Caribbean
RCL
$85.6B
| $892M | 0.68% |
2,756,921
-418,747
| -13% | -$140M |
|
45
BioMarin Pharmaceuticals
BMRN
$12.4B
| $825M | 0.63% |
15,229,287
-542,886
| -3% | -$31M |
|
46
Analog Devices
ADI
$190B
| $806M | 0.62% |
3,280,120
-166,160
| -5% | -$39.9M |
|
47
TransDigm Group
TDG
$67.7B
| $772M | 0.59% |
585,373
+27,450
| +5% | +$39.2M |
|
48
Intuit
INTU
$89B
| $766M | 0.59% |
1,121,452
-186,285
| -14% | -$134M |
|
49
Meta Platforms (Facebook)
META
$1.51T
| $742M | 0.57% |
1,010,840
-6,690
| -0.7% | -$4.98M |
|
50
Jabil
JBL
$35.8B
| $723M | 0.55% |
3,331,070
-79,340
| -2% | -$17.3M |
|
Similar funds
VAM
Primecap Management's Q3 2025 Portfolio in Review
As of Q3 2025, Primecap Management held 338 positions worth $131B, up 3.5% from $126B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Primecap Management withdrew a net $8.55B in Q3 2025, closing 11 positions and reducing 234 holdings. Its most notable exit was Hess, an estimated $1.06B position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Primecap Management opened a new position in Chevron worth $988M.
- Primecap Management's largest Q3 2025 buy was Chevron: 6,362,826 shares worth $988M.
- Primecap Management added most to Amazon in Q3 2025, an estimated $718M increase.
- Primecap Management's biggest Q3 2025 reduction was Eli Lilly, cutting an estimated $1.01B.
- Primecap Management fully exited Hess in Q3 2025, selling an estimated $1.06B.
- Primecap Management's ten largest holdings make up 32% of its $131B portfolio in Q3 2025.
- Primecap Management opened 5 new positions and closed 11 in Q3 2025.
- Primecap Management's portfolio value rose 3.5% quarter-over-quarter to $131B.
Based on Primecap Management's 13F filing for Q3 2025, filed 12 Nov 2025.